Fri, Aug 1, 2014, 10:16 AM EDT - U.S. Markets close in 5 hrs 44 mins

Recent

% | $
Click the to save as a favorite.

Astex Pharmaceuticals, Inc. Message Board

  • weightbayou weightbayou Apr 26, 2013 8:21 PM Flag

    Astex Pharmaceuticals is supplying the technology that allows AstraZeneca to develop it.

    A Lot of Promising Candidates
    With the help of Astex Pharmaceuticals (Nasdaq:ASTX), AstraZeneca (NYSE:AZN) is working on AZD-3839 - a drug that blocks the enzyme that may ultimately induce Alzheimer's. AstraZeneca owns the drug; Astex Pharmaceuticals is supplying the technology that allows AstraZeneca to develop it. It's called "Pyramid," and it's not only being used by AstraZeneca to develop this drug, but by several other companies looking to develop other small molecule therapies ... now that they can.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • AZD-3839

      Did you happen to review the actual trial? Interesting that it was completed in early 2012 and Astra zeneca hasn't moved it forward in over a year. This is why you have to be careful with this board, this is the same guy predicting $15 and now posting a drug that Astra Zenca dropped. Look three readers flag this as thumbs up. Meaning none of them actually research, if this info was true. You have another poster stating that the shorts made a profit on the stock rising.

      Well it's headed to $15 and they advancing a drug that they dropped.

      It's almost like I don't have to support my points, the current longs do the job for you. Tuesday morning reality hits. Specially when the focus will be costs rising and Dacogen generic impact.

      Sentiment: Sell

 
ASTX
8.4950.000(0.00%)Oct 10 4:00 PMEDT